Performance Reporting

Outcome 1 Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements

DELIVERABLE/
KEY PERFORMANCE
INDICATOR (KPI)
OBJECTIVE
SECURE THE SUPPLY OF BLOOD AND BLOOD PRODUCTS

New Australian Red Cross Blood Service contract arrangements are progressed

Reference Point/Target:

The second cycle of the Output Based Funding Model (OBFM), under the Deed of Agreement, is implemented. National Service Standards, Payment and Substitution Rules and the National Inventory Management Framework (NIMF) are progressed.

Result:

Met. Second cycle of OBFM implemented. First phase of National Service Standards agreed. NIMF for red blood cells pilots completed.
NBA funding jurisdictions are satisfied with planning, management and coordination of NBA activities Reference Point/Target:

Satisfaction is assessed through survey of Jurisdictional Blood Committee (JBC) members.

Result: Met. Results from 2013-14 survey indicated a high level of satisfaction that the NBA met this KPI.
Variance between actual and NBA estimated demand for supply of products Reference Point/Target:

<5 per cent.

Result: Substantially met. The demand for a number of fresh, plasma and recombinant products declined further than estimated as a result of better than anticipated take-up of improved clinical practice measures.
IMPROVE RISK MANAGEMENT AND BLOOD SECTOR PERFORMANCE
Review of the clinical and administrative management of IVIg is progressed Reference Point/Target:

Recommendations of the Review are implemented in accordance with governments’ decisions

Result: Met. Project business cases for new governance arrangements and supporting database approved by JBC. Delivery commenced.
Percentage of hospitals using BloodNet Reference Point/Target:

90 per cent.

 

Result: Met. 98 per cent of hospitals that receive blood.
PROMOTE THE SAFE AND EFFICIENT USE OF BLOOD AND BLOOD PRODUCTS
National data strategy is progressed Reference Point/Target:

Data governance arrangements are implemented and available to stakeholders by December 2013. Performance scorecard is implemented February 2014 and reviewed on ongoing basis.

Result: Partially Met. Data Governance Framework developed and subject to JBC consideration. Performance scorecard implementation commenced and 2013-14 results to be published on NBA website.
Number of clinical practice guidelines submitted for National Health and Medical Research Council (NHMRC) consideration Reference Point/Target:

One

Result: Met. Module 5 of the Patient Blood Management Guidelines (PBM) (Obstetrics) was submitted to NHMRC in June 2014 as part of the public consultation process.
Effective consultation with clinicians on options for the development of a comprehensive national patient blood management programme Reference Point/Target:

Satisfaction is assessed through surveys of all relevant stakeholders.

Result: Met. A high level of satisfaction indicated during formal and informal consultation and feedback processes involving clinical stakeholders.
Objectives
Secure the supply of blood and blood products Improve risk management and blood sector performance Promote the safe and efficient use of blood and blood products
Key Programmes and Initiatives